06/04/2026
🚨🚨🚨NEW PUBLICATION ALERT🚨🚨🚨
As myopia rates continue to rise globally, the conversation around when to intervene is becoming just as important as how.
Yesterday, the findings of a recent Canadian study by Amy Chow, Barbara Caffery, Angela Di Marco, Sarah Guthrie, Mira Acs, Stephanie Fromstein, Dr. Shalu Pal, Stephanie Ramdass, Vishakha Thakrar, Matthew Zeidenberg and Debbie Jones were published - the key findings of their study examining 1,740 pre-myopic children (ages 6–10) revealed a few important insights for clinical practice:
🔍 10.6% of pre-myopic children progressed to myopia over the study period
📉 Accelerated loss of hyperopic reserve was observed in more recent cohorts (2020–2021 vs. 2017)
👁️ ~92% of patients were monitored without intervention at initial visits
🌿 3.5% received lifestyle recommendations, despite evidence supporting their role in delaying onset
‼️ Most importantly: While progression risk appears to be increasing, clinical management patterns have remained largely unchanged.
This raises an important question for eye care professionals:
👉 Are we waiting too long to act?
With growing evidence that delaying myopia onset may have greater long-term impact than treating established myopia, proactive strategies in the pre-myopic phase deserve more attention.
As a profession, it may be time to rethink early intervention—especially when simple, low-risk measures (like increased outdoor time) are underutilized.
You can read the full study at https://www.mdpi.com/2077-0383/15/7/2748 - it's
💬 How are you approaching pre-myopia management in your practice?
School of Optometry & Vision Science
